Live from the NIH registry
Studies recruiting near Ogden right now
Top 25 of 113 recruiting studies, sorted by proximity — each links to its official registry page
Adaptation and Pilot Implementation of ePNa Clinical Decision Support for Utah Urgent Care Clinics
Pneumonia
N/A
Interventional 4,000 participants sought
South Ogden Instacare — South Ogden, Utah (2.5 mi)
· Sponsor: Intermountain Health Care, Inc.
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Non Small Cell Lung Cancer, c-MET
Phase 3
Interventional 768 participants sought
Community Cancer Trials of Utah - South Ogden /ID# 262829 — Ogden, Utah (0.4 mi)
· Sponsor: AbbVie
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
Relapsing Multiple Sclerosis, Multiple Sclerosis
N/A
Observational 2,000 participants sought
TG Therapeutics Investigational Trial Site — Ogden, Utah (0.4 mi)
· Sponsor: TG Therapeutics, Inc.
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Breast Cancer
Phase 3
Interventional 3,960 participants sought
Farmington Health Center — Farmington, Utah (17.6 mi)
· Sponsor: NRG Oncology
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Heart Failure
Phase 3
Interventional 11,300 participants sought
Research Site — Ogden, Utah (0.4 mi)
· Sponsor: AstraZeneca
A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata
Alopecia Areata
Phase 3
Interventional 674 participants sought
AMR Clinical — Layton, Utah (11.6 mi)
· Sponsor: Pfizer
A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma
Diffuse Large B-cell Lymphoma (DLBCL)
Phase 3
Interventional 904 participants sought
Community Cancer Trials of Utah — Ogden, Utah (0.4 mi)
· Sponsor: Regeneron Pharmaceuticals
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
NASH With Fibrosis, MASH With Fibrosis
Phase 3
Interventional 1,650 participants sought
Akero Clinical Study Site — Ogden, Utah (0.4 mi)
· Sponsor: Akero Therapeutics, Inc
A Study of Dotinurad Versus Allopurinol in Participants With Gout
Gout
Phase 3
Interventional 500 participants sought
Ogden Clinic Canyon View/RIO Clinical Trials — Ogden, Utah (0.4 mi)
· Sponsor: Crystalys Therapeutics
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes
Diabetes Mellitus, Type 1
Phase 3
Interventional 150 participants sought
Advanced Research Institute - Ogden — Ogden, Utah (0.4 mi)
· Sponsor: vTv Therapeutics
A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)
Irritable Bowel Syndrome
Phase 2
Interventional 420 participants sought
GSK Investigational Site — Ogden, Utah (0.4 mi)
· Sponsor: GlaxoSmithKline
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
Migraine
Phase 3
Interventional 1,059 participants sought
Pantheon Clinical Research /ID# 250703 — Bountiful, Utah (23.8 mi)
· Sponsor: AbbVie
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne
Acne
Phase 1, Phase 2
Interventional 800 participants sought
Alpine Research Association- Site Number : 8400050 — Layton, Utah (11.6 mi)
· Sponsor: Sanofi Pasteur, a Sanofi Company
Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
Peripheral Arterial Disease
Phase 3
Interventional 1,205 participants sought
Alpine Research Organization — Clinton, Utah (7.4 mi)
· Sponsor: Eli Lilly and Company
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
Alzheimer Disease, Agitation
Phase 3
Interventional 650 participants sought
Local Institution - 2612 — Bountiful, Utah (23.8 mi)
· Sponsor: Bristol-Myers Squibb
A Study of Brenipatide in Adult Participants With Major Depressive Disorder
Depressive Disorder, Major
Phase 3
Interventional 1,000 participants sought
Alpine Research Organization — Clinton, Utah (7.4 mi)
· Sponsor: Eli Lilly and Company
Evaluation of Outcomes Following In-office Tympanostomy Using the Tula® System: a Prospective, Multi-center Registry
Otitis Media With Effusion, Acute Otitis Media
N/A
Observational 200 participants sought
Ogden Clinic - Professional Center North — Ogden, Utah (0.4 mi)
· Sponsor: Smith & Nephew, Inc.
An Exploratory Efficacy and Safety Study of DFL24498 Topical Ophthalmic Solution Compared With Vehicle in Participants With Dry Eye Disease
Dry Eye Disease (DED)
Phase 2
Interventional 417 participants sought
Alpine Research Organization, Inc. — Clinton, Utah (7.4 mi)
· Sponsor: Dompé Farmaceutici S.p.A
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
COVID-19 SARS-CoV-2 Infection
Phase 3
Interventional 2,330 participants sought
Alpine Research Organization — Clinton, Utah (7.4 mi)
· Sponsor: Pfizer
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
Psoriasis, Overweight or Obesity
Phase 4
Interventional 200 participants sought
Tanner Clinic — Layton, Utah (11.6 mi)
· Sponsor: Eli Lilly and Company
A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis
Ulcerative Colitis
Phase 2
Interventional 99 participants sought
Investigational Site Number: 8400007 — Ogden, Utah (0.4 mi)
· Sponsor: Sanofi
A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age
Influenza, Human
Phase 3
Interventional 54,000 participants sought
GSK Investigational Site — South Ogden, Utah (2.5 mi)
· Sponsor: GlaxoSmithKline
Brexanolone Lifting Outcomes Of Moms
Depression, Postpartum, Postpartum Depression (PPD)
Phase 3
Interventional 120 participants sought
Lipocine Investigational Site — Clinton, Utah (7.4 mi)
· Sponsor: Lipocine Inc.
Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
Atopic Dermatitis
N/A
Observational 1,000 participants sought
Galderma Investigational Site 7085 — Bountiful, Utah (23.8 mi)
· Sponsor: Galderma R&D
Study of DONQ52 in Active Celiac Disease
Celiac Disease
Phase 2
Interventional 92 participants sought
Care Access Research - Ogden — Ogden, Utah (0.4 mi)
· Sponsor: Chugai Pharmaceutical